KFin Technologies Limited has approved a capital infusion of up to USD 2 Million in its wholly owned subsidiary, KFin Technologies (Singapore) Pte. Ltd., to support business expansion and strategic investment. The Board of Directors sanctioned the proposal on June 10, 2026, allowing the funds to be disbursed in one or more tranches. This move aims to strengthen the subsidiary's operations in the financial services industry, specifically in fund administration and financial technology solutions for global alternative investment managers.

The capital infusion will be made via cash consideration and will not alter the shareholding structure of KFin Technologies (Singapore) Pte. Ltd., which will remain a wholly owned subsidiary. The transaction is classified as a related party transaction conducted at arm’s length. No specific governmental or regulatory approvals are required for the proposed investment, as per the disclosure submitted to the exchanges.

KFin Technologies (Singapore) Pte. Ltd. was incorporated on June 19, 2025, under the laws of Singapore. Through its subsidiaries, including Ascent Fund Services Pte. Ltd., the entity provides fund administration, corporate solutions, and financial technology services. The subsidiary reported nil turnover for FY26, as operations were recently established.

The Board meeting, which commenced at 03:00 p.m. and concluded at 05:30 p.m., also reviewed compliance with the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure references SEBI’s Master Circular dated January 30, 2026, regarding the details of the investment.

Key Details of the Investment

KFin Technologies Limited will engage with institutional investors through a series of non-deal roadshows organized by Investec from June 15 to June 19, 2026. These meetings are intended to provide updates on the company's performance and strategy, with presentations consistent with the disclosures made on April 29, 2026. The schedule includes interactions in Hong Kong and Singapore, subject to changes due to exigencies.

Schedule of Meetings

The company's management will meet with various funds and analysts in one-on-one and group settings. The detailed schedule is as follows:

Regulatory Disclosure

The intimation was submitted pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing was signed by Alpana Kundu, Company Secretary and Compliance Officer, on June 10, 2026.